These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32759604)

  • 21. Efficacy of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Scheduled to Undergo Invasive Procedures.
    Nishida Y; Kawaoka T; Imamura M; Namba M; Fujii Y; Uchikawa S; Ohya K; Daijo K; Teraoka Y; Morio K; Fujino H; Nakahara T; Yamauchi M; Hiramatsu A; Tsuge M; Aikata H; Takahashi S; Hayes CN; Fukuhara T; Tsuji K; Arataki K; Nagaoki Y; Aisaka Y; Kamada K; Kodama H; Chayama K
    Intern Med; 2021 Mar; 60(6):829-837. PubMed ID: 33087674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study.
    Peng J; Ma SH; Liu J; Hou Y; Liu XM; Niu T; Xu RR; Guo CS; Wang XM; Cheng YF; Ni H; Hou M
    J Thromb Haemost; 2014 Apr; 12(4):497-504. PubMed ID: 24517219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lusutrombopag: First Global Approval.
    Kim ES
    Drugs; 2016 Jan; 76(1):155-8. PubMed ID: 26666417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-associated anti-glycoprotein (GP) IIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura mainly recognize cation-dependent conformations: comparison with the epitopes of serum autoantibodies.
    Kosugi S; Tomiyama Y; Shiraga M; Kashiwagi H; Mizutani H; Kanakura Y; Kurata Y; Matsuzawa Y
    Thromb Haemost; 1996 Feb; 75(2):339-45. PubMed ID: 8815587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic Review with Meta-Analysis: Efficacy and Safety of Lusutrombopag for Severe Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures.
    Orme ME; Bentley R; Marcella S; Peck-Radosavljevic M; Perard R; Wedemeyer H; Yoshiji H; Agarwal K; Dusheiko G
    Adv Ther; 2022 Sep; 39(9):4169-4188. PubMed ID: 35836089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura.
    Kuwana M; Okazaki Y; Ikeda Y
    J Thromb Haemost; 2009 Feb; 7(2):322-9. PubMed ID: 18826388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombocytopenia in Chronic Liver Disease: New Management Strategies.
    Nilles KM; Flamm SL
    Clin Liver Dis; 2020 Aug; 24(3):437-451. PubMed ID: 32620282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of autoantibodies against platelet glycoproteins Ib/IX and IIb/IIIa, and platelet-reactive anti-HIV antibodies in thrombocytopenic narcotic addicts.
    Gonzalez-Conejero R; Rivera J; Rosillo MC; Cano A; Rodriguez T; Vicente V
    Br J Haematol; 1996 May; 93(2):464-71. PubMed ID: 8639450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relationship between the expression of autoantibodies against platelet membrane glycoprotein and therapeutic effect in primary immune thrombocytopenia].
    Liu XF; Xue F; Zhang L; Zhou XL; Liu YZ; Liu W; Chen YF; Huang YT; Yang RC
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):610-3. PubMed ID: 23906456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-associated anti-GPIIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura recognizing epitopes close to the ligand-binding site of glycoprotein (GP) IIb.
    Kosugi S; Tomiyama Y; Honda S; Kato H; Kiyoi T; Kashiwagi H; Kurata Y; Matsuzawa Y
    Blood; 2001 Sep; 98(6):1819-27. PubMed ID: 11535516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Significance of detection of anti-GPIIb/IIIa antibody secreting B cells and platelet-specific antibody in patients with idiopathic thrombocytopenic purpura].
    Chen JF; Yang LH; Dong CX; Feng JJ; Liu XE; Lu YJ; Chang LX; Liu JQ
    Zhonghua Xue Ye Xue Za Zhi; 2010 Sep; 31(9):603-6. PubMed ID: 21122320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study.
    Nomoto H; Morimoto N; Miura K; Watanabe S; Takaoka Y; Maeda H; Sasaki T; Koyashiki Y; Kurata H; Numao N; Isoda N; Yamamoto H
    BMC Gastroenterol; 2020 Dec; 20(1):427. PubMed ID: 33317473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody.
    Kuwana M; Kaburaki J; Ikeda Y
    J Clin Invest; 1998 Oct; 102(7):1393-402. PubMed ID: 9769332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-associated antibody to glycoprotein IIb/IIIa from chronic immune thrombocytopenic purpura patients often binds to divalent cation-dependent antigens.
    Fujisawa K; Tani P; McMillan R
    Blood; 1993 Mar; 81(5):1284-9. PubMed ID: 7680243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Participation of bonth splenic CD(5)(+) and CD(5)(-) B lymphocytes in production of platelet glycoprotein-specific autoantibodies in chronic ITP].
    Lu B; Hou M; Lu L; Shi Y; He Q; Ma D; Zhang M
    Zhonghua Xue Ye Xue Za Zhi; 2002 Sep; 23(9):460-2. PubMed ID: 12482355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical significance of circulating B cells secreting anti-glycoprotein IIb/IIIa antibody and platelet glycoprotein IIb/IIIa in patients with primary immune thrombocytopenia.
    Chen JF; Yang LH; Chang LX; Feng JJ; Liu JQ
    Hematology; 2012 Sep; 17(5):283-90. PubMed ID: 22971534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Construction and clinical applications of a humanized phage library of platelet GPIIb/IIIa single chain Fv antibody].
    Ji XB; Hou M; Ma DX; Li LZ; Peng J; Wang L
    Zhonghua Nei Ke Za Zhi; 2005 Apr; 44(4):293-6. PubMed ID: 15924647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura.
    Kuwana M; Nomura S; Fujimura K; Nagasawa T; Muto Y; Kurata Y; Tanaka S; Ikeda Y
    Blood; 2004 Feb; 103(4):1229-36. PubMed ID: 14551140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic Assessment and Treatment Effect of Lusutrombopag in Child-Pugh Class C Patients: Review of Patient Data from Two Clinical Studies and Post-Marketing Surveillance.
    Flamm SL; Peck-Radosavljevic M; Fukuhara T; Bentley R; Katsube T; Ochiai T; Kano T; Tsukimura E; Sasaki R; Osaki Y
    Adv Ther; 2022 Sep; 39(9):4285-4298. PubMed ID: 35904722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The IgG subclasses of platelet-associated autoantibodies directed against platelet glycoproteins IIb/IIIa in patients with idiopathic thrombocytopenic purpura.
    Chan H; Moore JC; Finch CN; Warkentin TE; Kelton JG
    Br J Haematol; 2003 Sep; 122(5):818-24. PubMed ID: 12930395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.